Yale Jen
Stock Analyst at Laidlaw & Co.
(0.78)
# 3,951
Out of 4,984 analysts
13
Total ratings
15.38%
Success rate
-7.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.37 | +264.96% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $51.05 | +105.70% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $6.26 | +203.51% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.55 | +1,722.49% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $81.00 | -40.74% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.49 | +5,033.47% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.02 | +11,065.14% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $3.71 | - | 2 | Dec 22, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $0.71 | +1,308.65% | 1 | Aug 28, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Hold | n/a | $2.41 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $2.03 | +11,722.66% | 1 | Sep 6, 2022 |
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.37
Upside: +264.96%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $51.05
Upside: +105.70%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $6.26
Upside: +203.51%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.55
Upside: +1,722.49%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $81.00
Upside: -40.74%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.49
Upside: +5,033.47%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.02
Upside: +11,065.14%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.71
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.71
Upside: +1,308.65%
Alaunos Therapeutics
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.41
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $2.03
Upside: +11,722.66%